3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29764490 | Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo. | 2018 May 3 | 3 |
| 2 | 27169385 | Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia. | 2016 Aug | 1 |
| 3 | 26010414 | Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas. | 2015 Jun 30 | 1 |